Mercury Pharma Group Limited

Private Company Ticker Symbol™: (MERCPHP)

What's included with your PrivCo Report Purchase:

Next Actions on Mercury Pharma Group Limited:

Business Summary

Mercury Pharma Group Limited, is a privately-held pharmaceutical company, develops, manufactures, markets, and sells prescription pharmaceuticals and non-prescription medicines in the United Kingdom and internationally. The company was founded in 1991 and has its headquarters in Croydon, United Kingdom.

Overview & Corporate Organization

Basic Information

Company Tags:	PE Backed
Year Founded:	1991
Formerly Named:	Goldshield Group
Fiscal Year End:	12/31
Address:	12-16 Addiscombe Road No 1 Croydon
City:	Fairfield Ward
Country:	United Kingdom
Phone:	View
Fax:	View
Website:	www.mercurypharma.com

Corporate Organization

Subsidiaries:

Mercury Pharma (Generics) Limited

Mercury Pharma International Limited

Mercury Pharma Management Services Limited

Mercury Pharma Overseas Limited

Mercury Pharmaceuticals Limited

Industry Information

Industry Codes

PICS™:	700802™
NAICS:	View
SIC:	View

PrivCo Industries (Sector > Industry > Sub-Industry)

Healthcare > Pharmaceuticals > Pharmaceutical & Drug Manufacturing

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

Charts, Financials, and Statistics (Table Format)

Below are Mercury Pharma Group Limited financials and other business metrics displayed in table format.
Copy & Paste Financials Into Spreadsheet or

Export All Mercury Pharma Group Limited Financials To Excel

All data before 2006 is completely free to view! To access data from 2006 onward:

Worldwide
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Washington, D.C.
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Canada
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Europe (all countries)
UK
Germany
France
Italy
Europe (excluding UK)
Asia-Pacific (all countries)
Australia
China
Hong Kong
India
South Korea
Taiwan
Japan
Asia-Pacific (excluding India)
Latin America (all countries)
Middle East & Africa (all countries)

Get Full Access To This Report	or	Upgrade to PrivCo Premium
$99 Single Company Access		Instant Full Site-Wide Access *Currently 50% Off Until May. 31!*

Income Statement	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997
Gross Profit	View	View	View	£55,034,000	£52,185,000	£74,082,000	£71,020,000	£53,109,000	£39,715,000	£25,601,000	£18,977,000	£13,167,000
Depreciation	View	View	View	£655,000	£514,000	£477,000	£455,000	£319,000	£160,000	£158,000	£953,000	£388,000

Balance Sheet	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997
Current Assets	View	View	View	View	View	View	£29,385,000
Other Current Assets	View	View	View	View	View	View	£618,000
Intangible Assets		View	View	View	View	View	£36,752,000
Total Assets	View	View	View	View	View	View	£67,255,000	£77,692,000	£95,387,000	£109,358,000	£83,823,000	£68,118,000	£26,021,000	£18,935,000	£9,147,000
Current Liabilities	View	View	View	View	View	View	£25,181,000	£33,658,000	£36,770,000	£35,610,000	£26,576,000	£25,922,000	£11,647,000	£11,030,000	£5,232,000
Total Liabilities	View	View	View	View	View	View	£27,237,000	£34,353,000	£47,822,000	£58,184,000	£41,411,000	£33,009,000	£11,755,000	£12,872,000	£5,396,000
Dividends		View	View	View	View	View	£2,225,000	£1,295,000	£1,069,000	£1,613,000	£1,249,000	£942,000	£483,000	£318,000	£151,000

Employee Figures	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997
Total Employees	View	View	View	View	View	View	831	648	407	335	304	256	197	124	44

Financial Notes:
*	Mercury Pharma Group Limited fiscal year end: 12/31

	Date	Status	Target	Buyer	Deal Type	Price
Details	Aug. 2012	Completed	View	View	Secondary Sale Acquisition	View

	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997
Accounts Date	View	View	View	View	View	View	31 Mar 2005	31 Mar 2004	31 Mar 2003	31 Mar 2002	31 Mar 2001	31 Mar 2000	31 Mar 1999	31 Mar 1998	31 Mar 1997
Accounts Filed Until	View	View	View	View	View	View	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown	Unknown
Accounts Type	View	View	View	View	View	View	Full Accounts	Full Accounts	Full Accounts	Full Accounts	Full Accounts	Full Accounts	Full Accounts	Full Accounts	Full Accounts
Assets Current Misc														£2,000,000	£1,600,000
Audit Date	View	View	View	View	View	View	31 Mar 2005	31 Mar 2004	31 Mar 2003	31 Mar 2002	31 Mar 2001	31 Mar 2000	31 Mar 1999	31 Mar 1998	31 Mar 1997
Audit Fees	View	View	View	View	View	View	£165,000
Audit Qualification	View	View	View	View	View	View	No Adverse Comments	No Adverse Comments	No Adverse Comments	No Adverse Comments	No Adverse Comments	No Adverse Comments	No Adverse Comments	No Adverse Comments	No Adverse Comments
Auditors	View	View	View	View	View	View	Grant Thornton UK Llp	Grant Thornton UK Llp	Grant Thornton UK Llp	Grant Thornton UK Llp	Grant Thornton UK Llp	Grant Thornton UK Llp	Grant Thornton UK Llp	Grant Thornton UK Llp	Grant Thornton UK Llp
Capital Employed	View	View	View	View	View	View	£42,074,000	£44,034,000	£58,617,000	£73,748,000	£57,247,000	£42,196,000	£14,374,000	£7,905,000	£3,915,000
Cash	View	View	View	View	View	View	£6,168,000	£186,000	£2,433,000	£9,320,000	£6,707,000	£11,353,000	£9,676,000	£1,341,000	£1,500,000
Cost Of Sales				View	View	View	£28,959,000	£34,878,000	£30,838,000	£29,413,000	£17,404,000	£12,931,000	£9,051,000	£6,681,000	£4,840,000
Creditors	View			View	View	View	£5,023,000	£7,374,000	£7,642,000	£7,563,000	£8,819,000	£6,907,000	£2,199,000	£3,907,000	£2,297,000
Director Emoluments				View	View	View	£1,506,000	£1,292,000	£1,230,000	£1,050,000	£903,000	£732,000	£2,050,000	£351,000	£263,000
Fixed Assets	View	View	View	View	View	View	£37,870,000	£50,089,000	£60,622,000	£72,967,000	£61,706,000	£45,003,000	£9,993,000	£11,092,000	£2,435,000
Misc Current Liabilities	View	View	View	View	View	View	£20,158,000	£20,784,000	£22,948,000	£23,460,000	£17,097,000	£19,015,000	£9,448,000	£7,123,000	£2,935,000
Net Assets	View	View	View	View	View	View	£40,018,000	£43,339,000	£47,565,000	£51,174,000	£42,412,000	£35,109,000	£14,266,000	£6,063,000	£3,751,000
Net Worth	View	View	View	View	View	View	£3,266,000	(£5,417,000)	(£11,210,000)	(£20,466,000)	(£17,620,000)	(£9,558,000)	£4,895,000	(£4,348,000)	£1,654,000
Operating Profit	View	View	View	View	View	View	£3,666,000
Other Long Term Finance									£7,500,000	£10,697,000	£2,675,000
Post-Tax Profit	View	View	View	View	View	View	(£711,000)
Pre-Tax Profit	View	View	View	View	View	View	£3,346,000
Shareholder Funds	View	View	View	View	View	View	£40,018,000	£43,339,000	£47,565,000	£51,174,000	£42,412,000	£35,109,000	£14,266,000	£6,063,000	£3,751,000
Short Term	View							£5,500,000	£6,180,000	£4,587,000	£660,000
Solicitors	View	View	View	View	View
Stock				View	View	View	£11,301,000
Tangible Assets	View	View	View	View	View	View	£1,118,000	£1,333,000	£1,847,000	£1,327,000	£1,674,000	£336,000	£622,000	£681,000	£338,000
Tax	View	View		View	View	View	(£4,057,000)	(£3,917,000)	(£5,004,000)	(£5,357,000)	(£4,572,000)	(£3,386,000)	(£2,002,000)	(£1,351,000)	(£783,000)
Total Long Term Liabilities				View	View	View	£2,056,000	£695,000	£11,052,000	£22,574,000	£14,835,000	£7,087,000	£108,000	£1,842,000	£164,000
Trade Debtors				View	View	View	£11,298,000	£12,755,000	£14,499,000	£11,806,000	£6,663,000	£5,234,000	£1,643,000	£1,779,000	£860,000
Turnover	View	View	View	View	View	View	£83,993,000	£87,063,000	£104,920,000	£100,433,000	£70,513,000	£52,646,000	£34,652,000	£25,658,000	£18,007,000
Wages Salaries		View		View	View	View	£8,483,000

Choose Region(s):
Or Enter Location (US, CAN, UK): within miles
Annual Revenues search is available on PrivCo Premium. Upgrade to PrivCo Premium Subscription Annual Revenues:
Industry:
Go to Advanced Search

Mercury Pharma Group Limited

Business Summary

Overview & Corporate Organization

Basic Information

Corporate Organization

Industry Information

Industry Codes

PrivCo Industries (Sector > Industry > Sub-Industry)

Charts, Financials, and Statistics (Table Format)

Charts, Financials, and Statistics (Graphs)

Mercury Pharma Group Limited Gross Profit (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Depreciation (£, GBP): (Displayed as graph)

Mercury Pharma Group Limited Current Assets (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Other Current Assets (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Intangible Assets (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Total Assets (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Current Liabilities (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Total Liabilities (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Dividends (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Total Employees: (Displayed as graph)

Mercury Pharma Group Limited Audit Fees (£, GBP): (Displayed as graph)

Mercury Pharma Group Limited Capital Employed (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Cash (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Cost Of Sales (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Creditors (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Director Emoluments (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Fixed Assets (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Misc Current Liabilities (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Net Assets (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Net Worth (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Operating Profit (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Post-Tax Profit (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Pre-Tax Profit (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Shareholder Funds (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Short Term (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Stock (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Tangible Assets (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Tax (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Total Long Term Liabilities (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Trade Debtors (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Turnover (£ MM, GBP): (Displayed as graph)

Mercury Pharma Group Limited Wages Salaries (£ MM, GBP): (Displayed as graph)

Mergers & Acquisitions

Supplemental Resources

PrivCo Private Deals Newsletter.It's FREE!

Who We Serve

Problems We Solve

PrivCo

Mercury Pharma Group Limited Gross Profit (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Depreciation (£, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Current Assets (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Other Current Assets (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Intangible Assets (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Total Assets (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Current Liabilities (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Total Liabilities (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Dividends (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Total Employees:
(Displayed as graph)

Mercury Pharma Group Limited Audit Fees (£, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Capital Employed (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Cash (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Cost Of Sales (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Creditors (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Director Emoluments (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Fixed Assets (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Misc Current Liabilities (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Net Assets (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Net Worth (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Operating Profit (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Post-Tax Profit (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Pre-Tax Profit (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Shareholder Funds (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Short Term (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Stock (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Tangible Assets (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Tax (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Total Long Term Liabilities (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Trade Debtors (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Turnover (£ MM, GBP):
(Displayed as graph)

Mercury Pharma Group Limited Wages Salaries (£ MM, GBP):
(Displayed as graph)

PrivCo Private Deals Newsletter.
It's FREE!